Paper9034992
Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
Hasegawa M and 3 others. J Rheumatol, 1997. Cited by 281 papers, by iCite.
Cite this record
ConductScience Library. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. Papers, record 9034992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9034992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-10 | Major topic |
| Interleukin-13 | Major topic |
| Interleukin-4 | Major topic |
| Scleroderma, Systemic | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Blood Sedimentation | |
| C-Reactive Protein | |
| Child | |
| Enzyme-Linked Immunosorbent Assay | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Cited by132
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41102323 | Th1 and Th2 cells in equine endometrosis and their interactions with endometrial fibroblasts. | Sci Rep | 2025 | https://conductscience.org/library/papers/41102323 | PubMed |
| 39210206 | Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review. | Clin Rheumatol | 2024 | https://conductscience.org/library/papers/39210206 | PubMed |
| 38577035 | Biomarkers in skin autoimmunity-An update on localised scleroderma. | Skin Health Dis | 2024 | https://conductscience.org/library/papers/38577035 | PubMed |
| 38386070 | Emerging therapeutic targets in systemic sclerosis. | J Mol Med (Berl) | 2024 | https://conductscience.org/library/papers/38386070 | PubMed |
| 38357212 | Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease. | JID Innov | 2024 | https://conductscience.org/library/papers/38357212 | PubMed |
| 38327271 | Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: a preliminary explorative study. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/38327271 | PubMed |
| 38292323 | The Association of Telangiectasias with Other Peripheral Vascular Lesions of Systemic Sclerosis. | Clin Cosmet Investig Dermatol | 2024 | https://conductscience.org/library/papers/38292323 | PubMed |
| 38272806 | Global research status of localised scleroderma reported over the period 1993-2022: A 30-year bibliometric analysis. | Int Wound J | 2024 | https://conductscience.org/library/papers/38272806 | PubMed |
| 38139335 | Synthetic Nucleic Acid Antigens in Localized Scleroderma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38139335 | PubMed |
| 38129904 | SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis. | J Inflamm (Lond) | 2023 | https://conductscience.org/library/papers/38129904 | PubMed |
| 37630981 | Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37630981 | PubMed |
| 37603199 | Treatable Traits in Systemic Sclerosis. | Clin Rev Allergy Immunol | 2023 | https://conductscience.org/library/papers/37603199 | PubMed |
| 37392249 | Type 2 cytokines and scleroderma interstitial lung disease. | Clin Exp Med | 2023 | https://conductscience.org/library/papers/37392249 | PubMed |
| 36835506 | Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835506 | PubMed |
| 36726987 | Dysregulated B cell function and disease pathogenesis in systemic sclerosis. | Front Immunol | 2022 | https://conductscience.org/library/papers/36726987 | PubMed |
| 36629780 | STAT6 suppression prevents bleomycin-induced dermal fibrosis. | FASEB J | 2023 | https://conductscience.org/library/papers/36629780 | PubMed |
| 36352098 | Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis. | Nat Rev Rheumatol | 2022 | https://conductscience.org/library/papers/36352098 | PubMed |
| 36063053 | Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis. | Rheumatology (Oxford) | 2023 | https://conductscience.org/library/papers/36063053 | PubMed |
| 36015084 | Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36015084 | PubMed |
| 35997892 | The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases. | Adv Ther | 2022 | https://conductscience.org/library/papers/35997892 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL13 | 3596 | PubTator's text mining | https://conductscience.org/library/genes/3596 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9034992
GET https://conductscience.org/api/papers/v1/9034992/cited_by?page=2